Stimulating G protein-coupled receptors: cure or cause for heart failure?
Vatner
D E
DE
D058665:Adrenergic beta-1 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004195:Disease Models, Animal; D018014:Gene Transfer Techniques; D006333:Heart Failure / Q000209:etiology* / Q000235:genetics / Q000378:metabolism* / Q000628:therapy; D020962:Heterotrimeric GTP-Binding Proteins / Q000378:metabolism*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D009638:Norepinephrine / Q000172:deficiency / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D011817:Rabbits; D018342:Receptors, Adrenergic, beta-1 / Q000235:genetics / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism*; D018016:Receptors, Parathyroid Hormone / Q000235:genetics / Q000378:metabolism; D017483:Receptors, Vasopressin / Q000235:genetics / Q000378:metabolism
D058665:Adrenergic beta-1 Receptor Agonists; D000318:Adrenergic beta-Agonists; D018342:Receptors, Adrenergic, beta-1; D011956:Receptors, Cell Surface; D018016:Receptors, Parathyroid Hormone; D017483:Receptors, Vasopressin; D000242:Cyclic AMP; D020962:Heterotrimeric GTP-Binding Proteins; D009638:Norepinephrine